Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond

Monoclonal antibodies are an effective and growing class of pharmaceuticals for the treatment and prevention of a broad range of non-communicable and infectious diseases; however, most low- and middle-income countries have limited access to these innovative products. Many factors contribute to the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Gieber, Lisa, Muturi-Kioi, Vincent, Malhotra, Shelly, Sitlani, Ayesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141866/
https://www.ncbi.nlm.nih.gov/pubmed/37115494
http://dx.doi.org/10.1007/s40290-023-00473-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141866/
https://www.ncbi.nlm.nih.gov/pubmed/37115494
http://dx.doi.org/10.1007/s40290-023-00473-z

Ejemplares similares